Literature DB >> 29449010

A brief report of plexiform neurofibroma.

Mahdi Khajavi1, Shahrokh Khoshsirat2, Lida Ahangarnazari1, Niloofar Majdinasab1.   

Abstract

Plexiform neurofibroma (PNF) is a rare variant of neurofibromatosis type1 (NF-1), which histopathologically, is a subtype of benign nerve sheath tumors, neurofibromas (NF). It develops as a result of proliferation in all parts of peripheral nervous system and can cause the functional damage, deformities, pain, considerable mortality, and morbidity and even the increasing risk of malignant transformation in some critical cases. Currently, the surgical intervention is the treatment of choice for PNF patients, which due to the tumor invasion, massive growth, and the chance of postoperative regrowth is not possible. The diagnosis of isolated tumor is an uncommon event. Considering the rarity of this neoplasm, herein, we describe a case of isolated PNF, so the purpose of this presenting is the rarity of recording. We describe a case of isolated plexiform neurofibroma presented with 7-year history of a slowly growing postauricular soft subcutaneous mass in a 14-year-old boy, which caused the right auricular deformity. After initial evaluation by imaging studies, the patient underwent to surgical resection of the mass and the diagnosis of plexiform neurofibroma was confirmed by histopathologic examination. Surgical excision of the mass had been done before which concluded the satisfactory result and based on oncologist diagnosis, further intervention such as radiotherapy or chemotherapy was not needed. The patient left the hospital with a clinical stability and was suggested to continue the regular follow-up. In conclusion, considering neurofibroma (NF) as differential diagnosis for subcutaneous masses in head and neck area is critical for early diagnosis and treatment procedure.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Histopathological examination; Neurofibromatosis type1; Plexiform neurofibroma; Postauricular mass

Mesh:

Year:  2018        PMID: 29449010     DOI: 10.1016/j.currproblcancer.2018.01.007

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  2 in total

1.  Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1.

Authors:  Helen Toledano; Gad Dotan; Rivka Friedland; Rony Cohen; Iftach Yassur; Hagit Toledano-Alhadef; Shlomi Constantini; Mika Shapira Rootman
Journal:  Childs Nerv Syst       Date:  2021-03-22       Impact factor: 1.475

2.  The recurrent plexiform neurofibroma of the scalp in neurofibromatosis type 1: illustrative case.

Authors:  Galih Indra Permana; M Arifin Parenrengi; Wihasto Suryaningtyas; Dyah Fauziah; Muhammad Azzam
Journal:  J Neurosurg Case Lessons       Date:  2021-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.